Natixis Advisors’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,886
Closed -$887K 1651
2025
Q2
$887K Buy
+11,886
New +$787K ﹤0.01% 1338
2025
Q1
Sell
-15,294
Closed -$1.19M 1635
2024
Q4
$1.19M Buy
+15,294
New +$1.23M ﹤0.01% 1254
2024
Q3
Sell
-14,324
Closed -$1.19M 1606
2024
Q2
$1.19M Buy
14,324
+3,193
+29% +$281K ﹤0.01% 1196
2024
Q1
$950K Sell
11,131
-4,688
-30% -$368K ﹤0.01% 1234
2023
Q4
$1.35M Buy
15,819
+324
+2% +$28K ﹤0.01% 1116
2023
Q3
$1.39M Buy
15,495
+1,465
+10% +$131K ﹤0.01% 1085
2023
Q2
$1.2M Buy
14,030
+992
+8% +$83.9K ﹤0.01% 1119
2023
Q1
$1.08M Buy
+13,038
New +$1.06M ﹤0.01% 1121
2021
Q2
Sell
-15,578
Closed -$1.73M 1317
2021
Q1
$1.73M Sell
15,578
-2,740
-15% -$339K 0.01% 914
2020
Q4
$2.17M Sell
18,318
-644
-3% -$69.3K 0.01% 804
2020
Q3
$1.65M Buy
+18,962
New +$1.66M 0.01% 843
2018
Q3
Sell
-13,543
Closed -$1.22M 1085
2018
Q2
$1.22M Sell
13,543
-11,786
-47% -$995K 0.01% 892
2018
Q1
$1.85M Sell
25,329
-367
-1% -$25.2K 0.02% 763
2017
Q4
$1.49M Buy
25,696
+421
+2% +$22.2K 0.02% 784
2017
Q3
$1.13M Buy
25,275
+2,854
+13% +$119K 0.01% 849
2017
Q2
$885K Buy
+22,421
New +$921K 0.01% 892
2016
Q4
Sell
-13,104
Closed -$474K 1026
2016
Q3
$474K Buy
13,104
+1,037
+9% +$35.6K 0.01% 926
2016
Q2
$350K Buy
12,067
+1,729
+17% +$52.3K ﹤0.01% 933
2016
Q1
$362K Buy
+10,338
New +$334K 0.01% 933
2015
Q3
Sell
-72,371
Closed -$2.99M 1006
2015
Q2
$2.99M Sell
72,371
-27,294
-27% -$1.15M 0.05% 504
2015
Q1
$4.48M Sell
99,665
-82,075
-45% -$3.43M 0.08% 393
2014
Q4
$6.8M Buy
181,740
+29,157
+19% +$1.07M 0.13% 226
2014
Q3
$5.33M Sell
152,583
-92,442
-38% -$3.3M 0.11% 291
2014
Q2
$8.64M Buy
+245,025
New +$8.19M 0.12% 255
2014
Q1
Sell
-5,376
Closed -$226K 1253
2013
Q4
$226K Buy
5,376
+177
+3% +$7.28K ﹤0.01% 1091
2013
Q3
$207K Buy
5,199
+157
+3% +$6.59K ﹤0.01% 1073
2013
Q2
$209K Buy
+5,042
New +$204K ﹤0.01% 1013

Other funds holding HAE